Cargando…
Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
OBJECTIVE: Epidermal growth factor receptor (EGFR) specific mutations have been known to improve survival of patients with non-small-cell lung carcinoma (NSCLC). However, whether there are any changes of EGFR mutations after targeted therapy and its clinical significance is unclear. This study was t...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363800/ https://www.ncbi.nlm.nih.gov/pubmed/28333951 http://dx.doi.org/10.1371/journal.pone.0173524 |